Article
SGLT2 inhibition attenuates γδ T cell–mediated meta-inflammation associated with cardiometabolic risk in type 2 diabetes
2026-03-13
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> Cardiovascular and renal protection conferred by sodium–glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) extends beyond glucose lowering. Chronic low-grade meta-inflammation is a key driver of cardiometabolic risk in type 2 diabetes (T2D), yet the cellular mediators modified by modern antidiabetic therapy rema...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba3121ee-37cf-5e16-8b5a-7fc31935d261
- DOI
- 10.21203/rs.3.rs-9020037/v1
